The evaluation of transcatheter interventions for lymphatic complications after surgical repair in the patients with congenital heart disease.

The evaluation of transcatheter interventions for lymphatic complications after surgical repair in the patients with congenital heart disease. - The evaluation of transcatheter interventions for lymphatic complications after surgical repair in the patients with congenital heart disease.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000044195

Enrollment

Registered

2021-05-20

Start date

2021-05-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

protein losing enteropathy, plastic bronchitis, chylothorax

Interventions

transcatheter lymph embolization We perform the procedure under general anesthesia in cath labo or hybrid operation room. We embolize the abnormal lymph duct with lipid soluble contrast or n butyl-2-

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with refractory protein losing enteropathy, plastic bronchitis and chylothorax after surgery for congenital heart disease

Exclusion criteria

Exclusion criteria: patients with active bleeding, infection or allergy to lipid soluble contrast and n butyl-2-cyanoacrylate.

Design outcomes

Primary

Measure	Time frame
serum albumin, clinical symptoms, complications	—

Countries

Japan

Contacts

Public ContactKeijiro Ibuki

University of Toyama The devision of pediatrics

kibk9925@gmail.com076-434-7313

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026